{"id":6836,"date":"2025-03-06T15:20:45","date_gmt":"2025-03-06T13:20:45","guid":{"rendered":"https:\/\/www.institut-biotherapies.fr\/?p=6836"},"modified":"2026-05-21T11:21:18","modified_gmt":"2026-05-21T09:21:18","slug":"gene-therapy-trial-launched-for-sickle-cell-disease","status":"publish","type":"post","link":"https:\/\/www.institut-biotherapies.fr\/en\/2025\/03\/06\/gene-therapy-trial-launched-for-sickle-cell-disease\/","title":{"rendered":"Gene therapy trial launched for sickle cell disease"},"content":{"rendered":"<p>For the 7 million people living with sickle cell disease worldwide, the authorisation granted by the French National Agency for Medicines and Health Products Safety (ANSM) to launch the DREPAMIR phase I\/II clinical trial represents real hope. Supported by AFM-T\u00e9l\u00e9thon and led by Professor Marina Cavazzana and Dr Anne Galy (ART-TG), the aim of this trial is to provide a long-term therapeutic solution for affected patients.<\/p>\n<p><a href=\"https:\/\/www.afm-telethon.fr\/en\/news\/gene-therapy-trial-launched-sickle-cell-disease\">Read more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>For the 7 million people living with sickle cell disease worldwide, the authorisation granted by the French National Agency for Medicines and Health Products Safety (ANSM) to launch the DREPAMIR phase I\/II clinical trial represents real hope. Supported by AFM-T\u00e9l\u00e9thon and led by Professor Marina Cavazzana and Dr Anne Galy (ART-TG), the aim of this &hellip; <a href=\"https:\/\/www.institut-biotherapies.fr\/en\/2025\/03\/06\/gene-therapy-trial-launched-for-sickle-cell-disease\/\">[Read more]<\/a><\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-6836","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/posts\/6836","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/comments?post=6836"}],"version-history":[{"count":1,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/posts\/6836\/revisions"}],"predecessor-version":[{"id":6837,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/posts\/6836\/revisions\/6837"}],"wp:attachment":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/media?parent=6836"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/categories?post=6836"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/tags?post=6836"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}